Identifying the Main Culprits for Drug-Induced Tendinopathy
Drug-induced tendinopathy, including tendinitis and tendon rupture, is a potential side effect of certain medications. While the overall risk is low, recognizing these associations is vital, particularly for patients with additional risk factors. Several drug classes are consistently linked to tendon injuries in research and adverse event reporting.
Fluoroquinolone Antibiotics
This class, including ciprofloxacin, levofloxacin, and moxifloxacin, is strongly linked to drug-induced tendinopathy. They are thought to inhibit tenocyte function and stimulate enzymes that degrade the tendon's collagen matrix, compromising its structure. Symptoms can manifest rapidly or appear months after discontinuation. The Achilles tendon is most often affected, but other tendons like the rotator cuff, biceps, quadriceps, and hand tendons can also be involved. Risk factors include age over 60, concurrent corticosteroid use, kidney disease, and organ transplant.
Corticosteroids
Both systemic and injected corticosteroids are associated with tendon issues. They inhibit collagen synthesis and promote cell death in tendon tissues, delaying healing and weakening the tendon structure. Repeated local injections further elevate risk. Systemic effects often occur with prolonged use, while local injection effects can be delayed. Common sites for injury include the Achilles, patellar, and quadriceps tendons with systemic use, and hands and shoulders with local injections.
Statins
Statins, used for cholesterol reduction, are increasingly associated with tendinopathy, though the link is weaker than with fluoroquinolones. Statins may weaken the tendon matrix and impair tenocyte function. Onset is typically delayed by several months, affecting tendons in the Achilles, shoulder, and hands.
Aromatase Inhibitors
These breast cancer treatments in postmenopausal women are linked to musculoskeletal side effects, including tendinopathy. By blocking estrogen, which is important for connective tissue health, these drugs can affect tendon integrity. Symptoms can appear from weeks to over a year after starting treatment.
Management and Prevention of Medication-Related Tendinopathy
Managing drug-induced tendon issues requires recognizing potential adverse reactions and communicating them to a healthcare provider. Management and prevention strategies involve discontinuing the causative drug, rest, and rehabilitation, and assessing patient risk factors. Avoiding concurrent use of fluoroquinolones and corticosteroids is also advised. For further details on drug-induced tendinopathy and its clinical applications, consult {Link: Sciencedirect https://www.sciencedirect.com/science/article/abs/pii/S1297319X14001110}.
Conclusion
Fluoroquinolone antibiotics, corticosteroids, statins, and aromatase inhibitors are among the main drug classes linked to tendon injuries. Early recognition and management, including stopping the drug, rest, and rehabilitation, are essential to minimize debilitating damage. Patients should discuss medication concerns with their providers to ensure safe treatment that balances benefits and risks for tendon health.
[Authoritative Outbound Link]: Drug-induced tendinopathy: From physiology to clinical applications